Remove 2018 Remove BioTech Remove Health Policy Remove Medicare
article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

The bar chart shows that PhRMA (the advocacy group for the pharmaceutical industry), Blue Cross & Blue Shield Association, the American Hospital Association, and the American Medical Association (representing physicians) were four of the ten highest spending lobbyers in 2018. A recent study on politics and health care spending in the U.S.

article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.

BioTech 160
article thumbnail

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

prescriptions per person in 2018, two in three of which treated chronic conditions. In a call with analysts this week in which I participated, Murray Aitken discussed the report which looks back at 2018 and forward to 2023 with scenarios about what the U.S. Americans consumed 17.6 Welcome to Medicine Use and Spending in the U.S. ,

Medicare 149